Nivolumab With or Without Nab-Paclitaxel in Previously Treated, Advanced Stage, Non-small Cell Lung Cancer: A Randomized Phase II Study
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 23 Mar 2018
At a glance
- Drugs Nivolumab (Primary) ; Paclitaxel (Primary)
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- 16 Mar 2018 Status changed from recruiting to active, no longer recruiting.
- 30 Oct 2017 Status changed from not yet recruiting to recruiting.
- 21 Nov 2016 New trial record